Medline ® Abstract for Reference 18
of 'Neuroleptic malignant syndrome'
18
TI
Neuroleptic malignant syndrome after venlafaxine.
AU
Nimmagadda SR, Ryan DH, Atkin SL
SO
Lancet. 2000;355(9200):289.
A patient developed neuroleptic malignant syndrome after a single dose of venlafaxine with trifluoperazine treatment. A dopamine-inhibition effect induced by one dose of venlafaxine may have augmented dopamine-receptor inhibition by trifluoperazine.
AD
PMID